This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Gray Platelet Syndrome
Information about Gray Platelet Syndrome: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Gray Platelet Syndrome
Most recent studies have shown that Gray Platelet Syndrome shares some biological mechanisms with afibrinogenemia, bernard-soulier-syndrome, bleeding-tendency, blood-coagulation-disorders, blood-platelet-disorders, factor-v-quebec, fibrosis, hemorrhage, hemorrhagic-disorders, hermanski-pudlak-syndrome, leukemia, platelet-storage-pool-deficiency, pregnancy-complications-hematologic, primary-myelofibrosis, thrombasthenia, thrombocytopenic-purpura, tissue-adhesions, von-willebrand-disease, wiskott-aldrich-syndrome.
Among the many pathways, these few ones have gauged particular interests from scientists studying Gray Platelet Syndrome, and have been seen in publications frequently: Cell Adhesion, Cholesterol Efflux, Cholesterol Esterification, Coagulation, Constitutive Secretory Pathway, Endocytosis, Exocytosis, Hemostasis, Localization, Pathogenesis, Pigmentation, Platelet Activation, Platelet Aggregation, Platelet Formation, Prenylation, Protein Phosphorylation, Protein Targeting, Secretion, Secretory Pathway, Transport
Quite a number of genes have been found to play important roles in Gray Platelet Syndrome, such as ALB, ATP7A, ATP8A2, GATA1, GP6, HOXD13, ITGA2B, MDK, MVK, MYH9, PF4, PPBP, PRNP, RNF130, SELP, THBS1, TNC, VWF. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.